Brexanolone, a neurosteroid antidepressant, vindicates the gabaergic deficit hypothesis of depression and may foster resilience.

Bernhard Lüscher, Hanns Möhler

Research output: Contribution to journal › Review article › peer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Brexanolone, a neurosteroid antidepressant, vindicates the gabaergic deficit hypothesis of depression and may foster resilience.'. Together they form a unique fingerprint.

Neuroscience

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases